Skip to main content
AmigoFish

Psychedelics Today

Psychedelics TodayAudio

Format:
Podcast
New episodes:
Weekly
Typical length:
about 1 hour 20 minutes
Latest episode:
Not rated yet

About this show

Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.

Show details and episodes come from the publisher's public feed at rss.libsyn.com. Last updated . Names, artwork and text belong to their publishers.

Cosmos

Similar by topic and creator

See the full Cosmos

Similar shows

See all Health shows

Explore more

Episodes

  • PT 664 - Robert Rush - DEA Emergency Scheduling Abuse

    · 1 hr 26 min

    Attorney Robert Rush joins Joe in Breckenridge to talk about challenging DEA scheduling decisions, from the 2024 DOI and DOC hearing to the emergency scheduling of 7-OH compounds and SR-17018. They also look at what FDA approval of MDMA and psilocybin could mean if only the pharmaceutical versions get rescheduled.

    Not rated yet
  • PT 663 - Jackie Tileston - Penn Psychedelic Collaborative

    · 1 hr 13 min

    Jackie Tileston, a painter and Professor of Fine Arts at the University of Pennsylvania, brings decades of nondual practice and a working artist's eye to the question of what psychedelics, mysticism, and art have to teach each other. In this episode, Joe talks with Jackie about the Penn Psychedelics Collaborative and the course she co-teaches, Psychedelic Paradigms and Practices, why the mystical experience keeps showing up in clinical trials, the differences between nondual traditions and why they matter for integration, how 5-MeO-DMT is likely to fare in a clinical setting, what a good landing space after a session might look like, and why she thinks most psychedelic art is a postcard from the trip rather than an invitation into one. If a psychedelic experience can leave someone convinced that the world is an illusion, who in the room is prepared to help them come back? Enjoy the show. Recorded October 6, 2026 at Jackie's office at Penn In This Episode - The origins of the Penn Psychedelics Collaborative and the PhilaDelic conferences - Teaching Psychedelic Paradigms and Practices, supported by the SNF Paideia Program - Thirty years of meditation and nondual study before her first psychedelic experience - How David Yaden first came through her classroom - The debate over dropping the word mysticism from research - Why mystical experience scores predict better outcomes, and why researchers dislike that - A shift from materialism-first to consciousness-first thinking - How nondual lineages differ, and Abhinavagupta's critique of Advaita - Ontological trauma after high-dose nondual experiences - Meditation-related harms and Cheetah House - Should facilitators have their own psychedelic experience? The Sherpa analogy - Clinical 5-MeO-DMT and the case for low-dose, stepwise protocols - Designing landing spaces after a session without setting too many priors - Psychedelic art as a postcard from the trip, and abstraction as an invitation - Bruce Damer, the Center for MINDS, and James Fadiman's creative problem-solving studies - Christof Koch's 5-MeO-DMT experience and conversation with Bernardo Kastrup - David Eagleman's Possibilianism and Christopher Timmermann's neurophenomenology - Why worldview change may be the most political act Links - Jackie Tileston: https://jackietileston.com - Penn Psychedelics Collaborative: https://www.pennpsychedelicscollaborative.org - Psychedelic Paradigms and Practices: https://snfpaideia.upenn.edu/course/spring/2027/psychedelic-paradigms-and-practices-2/ - The Pattern Project: https://patternproject.substack.com/p/start-here-the-pattern-project - Cheetah House: https://www.cheetahhouse.org - Then I Am Myself the World by Christof Koch: https://www.hachettebookgroup.com/titles/christof-koch/then-i-am-myself-the-world/9781541602809/

    Not rated yet
  • PT 662 - Jordan Kronick - PEAKING

    · 1 hr 8 min

    Joe sits down with Jordan Kronick, the director, writer, and producer of Peaking: Psychedelics and the Pursuit of Happiness, a new documentary now rolling out in theaters city by city. The film covers six substances (psilocybin, LSD, ayahuasca, ibogaine, MDMA, and 5-MeO-DMT from the toad) and puts cameras inside the dosing room. Viewers follow first-time users before, during, and after their experiences. Jordan's path into this work goes back to 2003, when he produced Ecstasy Rising for Peter Jennings at ABC News. That primetime documentary challenged the government's "holes in your brain" campaign, and the scientist behind the flawed study retracted it before the film aired. Rick Doblin credits that moment with helping open the door to MAPS' first MDMA for PTSD research. Joe and Jordan talk about brain injury in pro sports, including Daniel Carcillo's story and a planned Johns Hopkins study on concussions. They cover the film's "big tent" approach and how Jordan found subjects through Heroic Hearts Project and Beond in Cancun. Joe raises his concerns about toad sustainability and safety. From there they get into the drug war's echoes from the 1960s to the 1980s, the Starck Club in Dallas, and Michael Clegg, the man credited with naming ecstasy. They close on today's bipartisan support for psychedelics, the road to FDA approval for Compass Pathways and Lykos, and the strange prospect of psychedelics becoming federally legal before cannabis. About Jordan Kronick Jordan Kronick is a documentary filmmaker who began his career at ABC News as a producer for Peter Jennings Reporting, where he made Ecstasy Rising (2004). He later worked at HBO's Real Sports with Bryant Gumbel, reporting on psychedelics in sports in 2020. Peaking premiered in June 2026 at Dances With Films at the TCL Chinese Theatre in Los Angeles. In this episode - Making a six-substance documentary in 19 months, from March 2024 to October 2025 - How Ecstasy Rising debunked the MDMA neurotoxicity campaign - Psychedelics, concussions, and CTE in the NHL, NFL, and MMA - Daniel Carcillo and a planned Johns Hopkins study on brain repair - Following veterans to the Amazon with Heroic Hearts Project - Ibogaine for opioid addiction at Beond in Cancun - Toad in the California desert, plus Joe's caution on sustainability and the myth of ancestral use - Clinical versus experiential approaches to psychedelic work - How the 1980s MDMA crackdown mirrored the 1960s - The Starck Club, Michael Clegg, and why ecstasy spread so fast - Rick Perry, veterans, and bipartisan support for ibogaine - Compass Pathways, Lykos, patents, and what FDA approval would and wouldn't legalize - Psychedelics leapfrogging cannabis Chapters - 00:00 Intro - 04:15 Meet Jordan Kronick and Peaking - 05:38 From the LA premiere to a city by city theatrical release - 08:39 Ecstasy Rising and the "holes in your brain" campaign - 13:01 Following the renaissance, and psychedelics in sports at HBO - 19:33 Can psychedelics repair the brain? - 22:19 Designing a "big tent" film - 26:05 Witnessing transformation in the dosing room - 28:10 Finding the subjects - 32:47 Toad: wild edges and real concerns - 38:46 Access in Oregon and Colorado - 41:12 The drug war, 1960s and 1980s - 47:58 Rick Doblin's role - 49:30 Archival footage and early research - 51:08 Michael Clegg, Texas, and the Starck Club - 56:30 Bipartisan support and ibogaine in Texas - 58:16 What's next with the FDA - 1:02:36 Psychedelics before cannabis? - 1:04:40 Where to see Peaking

    Not rated yet
  • PT 661 - Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health

    · 1 hr 15 min

    Kenneth Tupper has spent decades working at the intersection of drug policy, public health, harm reduction, education, and psychedelics. In this episode, Joe Moore talks with Tupper about his early work with DanceSafe and drug checking, British Columbia's overdose crisis and experiment with decriminalization, and what the psychedelic field can learn from decades of harm reduction work and research. They also dig into Tupper's academic work on psychedelics and education, the idea of entheogens as "plant teachers," ayahuasca policy in Canada, problems with conventional drug education, and the limits of treating psychedelics exclusively as medicines. The conversation eventually widens into a bigger question: What does it actually mean to educate people well about drugs, altered states, and consciousness? Enjoy the show. Disclaimer: Intro and promotional audio in this episode were generated using synthetic voice technology. The interview itself is unaltered. Show Notes (Machine Generated) Kenneth Tupper's career has followed two parallel tracks: psychedelic scholarship and public health. Long before the current psychedelic resurgence, he was studying the idea of entheogens as tools for learning and examining how Indigenous traditions understand plants such as ayahuasca, peyote, and psilocybin as teachers. At the same time, work with DanceSafe and early pill testing drew him into harm reduction and eventually into more than two decades of public-health and drug-policy work in British Columbia. Tupper and Joe revisit the early history of drug checking and the logic behind harm reduction: if people are going to use drugs, providing accurate information and reducing preventable risks can save lives. That discussion leads into supervised consumption sites, pharmaceutical alternatives to illicit opioids, fentanyl, the toxic drug supply, naloxone, and the difficult reality of people surviving overdoses while sustaining hypoxic or anoxic brain injuries. They also examine British Columbia's experiment with drug decriminalization. Tupper describes the limits of decriminalizing possession without simultaneously addressing housing, healthcare, treatment options, the illicit supply, and other social conditions. The conversation contrasts British Columbia with Portugal and explores why drug policy interventions cannot easily be transplanted from one social and historical context into another. From there, the discussion turns directly toward psychedelics. Tupper argues that psychedelic public health should involve more than clinical treatment. Psychedelics may have roles in health promotion, community building, education, rites of passage, and helping people who are not necessarily diagnosed with a psychiatric disorder. At the same time, wider access creates a need for better harm-reduction information, screening, preparation, and attention to set, setting, and the larger social environment in which psychedelic experiences occur. Drug education becomes one of the central themes of the episode. Tupper compares the history of drug education with sex education and argues that drug education has remained unusually tied to prescribed behavioral outcomes—particularly abstinence. Rather than simply telling young people what not to do, he asks what genuine education about drugs might look like when curiosity, experimentation, risk, pleasure, and real-world access are acknowledged. That question connects back to Tupper's longstanding work on what he calls entheogenic education. Drawing on educational thinkers including John Dewey and Lev Vygotsky, he discusses psychedelics as potential "cognitive tools" and considers how experiential education might offer models beyond conventional schooling. Joe and Tupper also discuss how AI may force an even deeper reconsideration of education when reading, writing, calculation, and information retrieval can increasingly be outsourced to machines. The final part of the conversation focuses heavily on…

    Not rated yet
  • PT 660 - Josh Lipson & Roman Palitsky: Psychedelic Harms and the Post-Psychedelic Challenges Study

    · 1 hr 12 min

    This is an important discussion about harms, and what we should be doing about them. Josh and Roman are working on a major study at Emory University to answer some of the basic and outstanding questions we have about psychedelic risks and cases that can be challenging to recover from. We have a lot of work to do characterizing these experiences, and developing appropriate treatments for helping people bounce back more quickly.

    Not rated yet
  • PT 659 - Megan Bowers & Mikayla Hellwich

    · 1 hr 20 min

    This is a special episode featuring two of our favorite organizations. DanceSafe and Shulgin Foundation. Listen to Joe Moore record with the heads of these orgs and learn about how you may be able to buy some art to support them. This is a singularly important history and partnership.

    Not rated yet
  • PT 658 - Mareesa Stertz – Sphinx Gate Beyond Burning Man: Psychedelic Healing Without Psychedelics

    · 1 hr 15 min

    My friend Mareesa joins us again on PT to discuss art, integration, psychedelic experiences without drugs, the heros journey and her smaller sphinxes that may start touring the country! Enjoy! Here are some machine generated shownotes if you find them useful! Show Notes Sphinx Gate began as a pair of monumental 34-foot sculptures at Burning Man. Now, Mareesa Stertz and her collaborators are developing smaller, portable versions that could bring the experience to festivals, conferences, and communities around the country. The installation is designed as a sober rite of passage—one that draws on psychedelic experience without requiring anyone to take a drug. Participants move through four portals centered on the mind, body, heart, and destiny. Along the way, they are invited to identify a recurring personal story, notice how it lives in the body, meet it with greater compassion, and consider what might exist beyond it. Mareesa and Joe explore how the project draws from the Hero's Journey, Carl Jung's concept of individuation, participatory art, ritual, somatic awareness, and the riddles traditionally associated with the sphinx. They also discuss the importance of community in psychedelic integration, the stories and inherited beliefs that disrupt self-trust, and why healing is rarely the result of one dramatic experience. The conversation expands into peer support, the Global Psychedelic Society, the risks of presenting psychedelics as a quick fix, and the challenge of remaining fully human as artificial intelligence becomes more embedded in everyday life.

    Not rated yet
  • PT 657 - Rachel Turetzky PhD & Douglas S. Wingate DTCM: The Eight-Circuit Model, Metaprogramming, and Psychedelic Therapy

    · 1 hr 18 min

    Kyle and Joe interview Rachel Turetzky & Douglas S. Wingate about their perspectives on the Wilson\Leary 8 Circuit Model of consciousness. They recently released a CE approved program on Psychedelic Education Center to train therapists on this model and how to integrate the 8 Circuit Model into your clinical therapy practice. In this episode: - Maybe Day and maybe logic: Honoring Robert Anton Wilson and learning to hold beliefs, models, and interpretations more lightly - Reality tunnels: How biology, experience, culture, and conditioning filter our perception of reality - Robert Anton Wilson's legacy: Guerrilla ontology, stand-up philosophy, Prometheus Rising, and using humor to destabilize rigid beliefs - Timothy Leary beyond the caricature: His early work in psychology, the development of the Eight-Circuit Model, and the parts of his intellectual legacy that are often overlooked - The first four circuits: Bodily safety, emotional territory, language and symbolic thinking, and social and relational conditioning - The upper circuits: Sensory and somatic intelligence, metacognition, archetypal and transpersonal experience, and unitive states of consciousness - Metaprogramming: Identifying the beliefs, imprints, and automatic patterns shaping our lives—and developing the capacity to revise them - Circuit Zero and Stanislav Grof: Prenatal and perinatal experience, the basic perinatal matrices, and the lasting influence of early development - Normalizing unusual experiences: Archetypal encounters, ancestral material, entities, out-of-body experiences, synchronicities, and other phenomena that conventional psychology may struggle to interpret - Psychedelics and re-imprinting: How expanded states may loosen entrenched developmental patterns and create opportunities for psychological change - Pleasure as therapeutic material: Anhedonia, chronic survival states, the "hedonic intelligence" of Circuit Five, and learning to experience joy without treating it as a distraction from the work - Clinical applications: Using the model during psychedelic preparation to identify intentions, developmental imprints, and material that may emerge - Medicine and dosage selection: How MDMA, ketamine, psilocybin, LSD, and 5-MeO-DMT may produce different experiences depending on the intention and dose - Integration and verticality: Grounding expansive, archetypal, or unitive experiences through the body, emotions, relationships, and everyday life - Chapel Perilous: Understanding destabilizing experiences, ontological shock, spiritual emergencies, and the process of reconstructing meaning afterward - Beyond psychedelics: Connections with yoga, meditation, occult practice, Chinese medicine, chakra systems, and other psychospiritual traditions - The new course: The structure of The Eight-Circuit Model of Consciousness: An Integrative Framework for Psychedelic-Assisted Therapy, including its 14 lessons, practical exercises, assessments, certification, and continuing-education options

    Not rated yet
  • PT 656 - Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture

    · 1 hr 43 min

    Denver mushroom decriminalization changed the national conversation around psilocybin access, personal use, and grassroots psychedelic reform. In this episode of Psychedelics Today, Joe Moore speaks with Travis Tyler Fluck, an autognostic mycologist, educator, activist, end-of-life doula, and longtime Colorado mushroom community organizer. Fluck was involved in Denver's 2019 psilocybin campaign, which made adult personal use and possession of psilocybin mushrooms the city's lowest law enforcement priority. The campaign passed by a narrow margin and helped open the door for later reforms in Oakland, Washington, D.C., Oregon, Colorado, and beyond. This conversation looks at the people, ethics, and tensions behind Denver mushroom decriminalization. It also explores what happens after a law changes: how communities educate themselves, how personal use spaces develop, and how grassroots access fits alongside regulated psychedelic services.

    Not rated yet
  • PT 655 - Martha Hammel and Tasia Poinsatte - Aspen Psychedelic Symposium

    · 54 min

    Aspen Psychedelic Symposium is the focus of this conversation with Martha Hammel of the Aspen Psychedelic Resource Center and Tasia Poinsatte of Healing Advocacy Fund. They join Joe Moore to discuss this year's symposium, how it fits into Colorado's evolving natural medicine landscape, and why Aspen has become a strong setting for serious public conversations about psychedelics. Hammel explains that the symposium is now in its third year and is designed to bring major psychedelic voices to Colorado's West Slope. She also outlines the local roots of the Aspen Psychedelic Resource Center, which grew out of education and outreach work around decriminalization and the Natural Medicine Health Act. Poinsatte describes Healing Advocacy Fund's broader role across Oregon, Colorado, and New Mexico, where the group works on safe access, implementation, affordability, and public education.

    Not rated yet
  • PT 654 - Erica Rex - Seeing What Is There

    · 1 hr 20 min

    Seeing What Is There is at the center of this conversation with journalist and author Erica Rex, who joins Joe Moore to discuss her book Seeing What Is There: My Search for Sanity in the Psychedelic Era. Rex brings an unusual mix of personal experience and scientific rigor. She came to psychedelic medicine after breast cancer, participation in Roland Griffiths' clinical trial for cancer-related depression, and a long career in journalism covering science, nature, climate, and technology.

    Not rated yet
  • PT 653 - Dr. Michael Alpert and Peter Alberding - ALS, Existential Distress, and Ketamine Therapy

    · 1 hr 19 min

    ALS and ketamine therapy are at the center of this conversation with psychiatrist Dr. Michael Alpert and Peter Alberding, who was diagnosed with ALS (https://en.wikipedia.org/wiki/ALS) in late 2023. Alpert is a Boston-area psychiatrist with experience in MDMA-assisted therapy research for PTSD and a private practice that includes ketamine-assisted psychotherapy. Alberding shares what it has been like to face a fatal neurodegenerative illness while working with ketamine in a structured clinical setting. Alberding explains that he was not looking for a casual psychedelic experience. He wanted help facing fear, grief, loss of function, and the reality of death. Over time, ketamine-assisted psychotherapy became a tool for processing those changes more directly than talk therapy alone had allowed.

    Not rated yet
  • PT 652 - Esme Dark - Psychedelics, Somatics and the Shadow

    · 1 hr 14 min

    Dr. Esme Dark joins Kyle Buller for a conversation on psychedelic therapy, somatic psychotherapy, and shadow work. Based in Australia, Dark is a clinical psychologist, somatic psychotherapist, and psychedelic therapist. She shares her perspective on Australia's authorized prescriber model, the role of psychotherapy in psychedelic care, and what it means to work with the body before, during, and after a psychedelic experience. The discussion stays practical. Dark draws on her work in research settings, including psilocybin-assisted psychotherapy for generalized anxiety disorder at Monash University. She explains that Australia has not decriminalized psychedelics. Instead, psilocybin and MDMA can be prescribed in limited cases through a psychiatrist-led system. That distinction matters, especially as public discussion often moves faster than the actual clinical infrastructure. Kyle and Dark also explore what happens in the therapy room. They talk about nervous system activation, body-based awareness, co-therapy, breathwork, and the challenge of knowing when to intervene and when to stay out of the way. The episode also turns toward creativity, self-expression, and the parts of the self that often remain split off or underdeveloped.

    Not rated yet
  • PT 651 - Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics

    · 1 hr 22 min

    MAPS co-executive directors Betty Aldworth and Ismail Ali join Psychedelics Today to talk about leading one of the most visible organizations in the psychedelic field during a period of transition. The conversation covers their move into permanent leadership, how they work together, and how MAPS is thinking about research, education, policy, and movement strategy after a difficult period for the organization and the broader field.

    Not rated yet
  • PT 650 - Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape

    · 1 hr 6 min

    Jen Davenport joins Psychedelics Today to interview co-founder Joe Moore about the growth of Psychedelics Today, the broader psychedelic ecosystem, and how professionals are beginning to engage with psychedelic ideas. Davenport is the founder of Iron Thread Partners and a graduate of the Vital psychedelic training program. Her work focuses on executive leadership, decision making, and organizational development. In this conversation she asks Moore about the evolution of Psychedelics Today and the changes he has witnessed across the psychedelic field over the past decade. Moore explains that Psychedelics Today began as a podcast exploring psychedelic research, therapy, and culture. Over time the project expanded into a media and education platform covering psychedelic science, harm reduction, and professional training. The organization now produces podcasts, journalism, courses, and public conversations about psychedelics and their place in modern society. A central part of the discussion is psychedelic integration. Moore notes that insight during a psychedelic experience does not automatically lead to lasting change. The integration process often requires continued work through journaling, meditation, therapy, and community support. These practices help people translate insights into stable changes in behavior and perspective. The conversation also explores policy changes in the United States. Colorado's Natural Medicine framework is creating a regulated system for psychedelic services while the state also maintains a broader decriminalization approach. Moore discusses the tension between regulated access and grassroots psychedelic culture, as well as the questions around accessibility, pricing, and corporate participation. Davenport asks how executives and professionals are approaching psychedelics. In some circles psychedelics are framed as tools for creativity or performance. Moore cautions against this framing. Psychedelics often open difficult personal material and should be approached with care rather than treated as productivity tools. Education remains a recurring theme throughout the episode. As public interest grows, Moore stresses the importance of studying the legal landscape, understanding the scientific literature, and developing responsible practices for preparation and integration. The conversation offers a grounded look at how Psychedelics Today approaches the psychedelic resurgence. Rather than focusing on hype, Moore emphasizes education, safety, and thoughtful engagement with psychedelic experiences.

    Not rated yet
  • PT 649 - Melissa Lavasani and Jay Kopelman

    · 1 hr 10 min

    Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: - Standardized safety protocols across providers - Integration support, not medication alone - Clear training pathways for clinicians - Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: - Veterans are likely the first federal pathway - Public education remains essential - Safety standards must be shared and transparent - Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing…

    Not rated yet
  • PT 648 - Enamory - Couples Therapy with Ketamine

    · 1 hr 23 min

    Enamory is a clinical practice, training institute, and nonprofit research organization focused on psychedelic assisted couples therapy. In this episode, clinical psychologists Chandra Kian and Kayla Knopp discuss their work integrating ketamine assisted psychotherapy with evidence based couples therapy models. Both guests trained as academic researchers at the University of California San Diego Veterans Affairs system, where they worked on large scale couples based PTSD trials. They later co founded Enamory to continue clinical work, train therapists, and conduct research focused specifically on relationships. Early Themes in Enamory and Couples Therapy The conversation begins with Dr. Kian and Dr. Knopp describing their background in couples based PTSD research and how that work shaped their clinical approach. They explain how existing couples therapy models often stall when partners cannot soften, access vulnerability, or understand each other's internal experience. Their early exposure to MDMA assisted therapy research highlighted how psychedelic states can temporarily reduce defensiveness and rigid narratives.

    Not rated yet
  • PT 647 - Joshua White: Fireside Project and Lucy, an AI Training Simulator for Psychedelic Support

    · 1 hr 11 min

    Fireside Project (https://firesideproject.org/) is a nonprofit that helps reduce the risks of psychedelic experiences through a free support line, coaching, education, and research. In this episode, Joshua White speaks with Psychedelics Today about why real-time support matters, what it takes to run a national hotline, and what Fireside learned after more than 30,000 conversations since launch. White shares how his background as a lawyer and his early hotline volunteering shaped Fireside's model. He also describes how festival harm reduction work, including lessons from Zendo-style support spaces, revealed a major gap: people often need help during an experience and after it ends. A major focus of the conversation is Lucy, Fireside's new voice-to-voice role-play simulator designed to improve psychedelic support skills through low-stakes practice. Early Themes With Fireside Project Joshua White introduces Fireside Project as an accessible safety net for people who are actively having psychedelic experiences or processing past ones. The support line launched on April 14, 2021, and relies on trained community volunteers who commit to a year of service. White explains why anonymity matters. He argues that a phone-based container can make it easier for callers to share vulnerable material without fear of judgment. He also frames service as a key part of integration for volunteers who want to give back or prepare for work in the psychedelic field. Core Insights From Fireside Project White describes the early difficulty of building Fireside from scratch, including legal design, insurance hurdles, training development, and fundraising. He credits seed support from David Bronner and Dr. Bronner's for helping Fireside prove that people would actually use a psychedelic support line. He also explains a key harm reduction point: calling emergency services during a non-medical psychedelic crisis can escalate risk. Fireside aims to help people regulate, re-orient, and stay safer when panic or fear shows up. Key concepts discussed include: - The thin line between healing and traumatizing during high-intensity psychedelic states - Why callers often need connection, not rescue - How volunteer capacity and call volume shape how long conversations run - The difference between support during an experience and longer-term coaching support Later Discussion and Takeaways With Fireside Project The conversation then turns to Lucy, a training tool White describes as a "flight simulator" for psychedelic practitioners. Lucy is not part of the live support line. Instead, it offers emotionally responsive role-play scenarios so trainees can practice staying grounded, tracking consent and boundaries, and responding to crisis cues. White also addresses recording and consent. He argues Fireside needs strong training feedback loops to improve safety and quality. He describes an anonymization approach designed to remove phone numbers, strip identifying details, and distort voices while preserving emotional tone. He also explains the post-call option for callers to delete their recorded conversation. Practical takeaways include: - Simulation can help trainees stay regulated when intense material emerges - Better training can reduce unnecessary diversion to emergency rooms - Clear consent language and easy deletion workflows matter for trust - Coaching can expand the continuum of psychedelic support beyond therapy

    Not rated yet
  • PT 646 - Manvir Singh: Shamanism the Timeless Religion

    · 1 hr 8 min

    Manvir Singh joins Psychedelics Today to unpack what shamanism means and why the term matters now. Singh is an anthropologist and author of Shamanism: The Timeless Religion. He argues that shamanism is not limited to "remote" societies or the past. Instead, it reliably reappears because it helps humans manage uncertainty, illness, and the unknown. This episode is relevant for the psychedelic community because "shaman" often gets used loosely, or avoided entirely. Singh offers a clear framework for talking about shamanic practice without leaning on romantic myths, drug-centered assumptions, or rigid definitions that do not fit the cross-cultural record. Early Themes With Manvir Singh Early in the conversation, Manvir Singh explains why many classic definitions of shamanism break down when tested across cultures, including in Siberia where the term originated. He discusses how popular images of shamanism often center "soul flight" and fixed cosmologies. However, ethnography shows more variation, including possession, spirit proximity, and different ways practitioners describe altered experience. Singh also traces his path into anthropology, including long-term fieldwork with the Mentawai people off the west coast of Sumatra. There, he studied ritual specialists known as kerei and saw how central they are to healing, ceremony, and community life. Core Insights From Manvir Singh At the center of the episode, Manvir Singh offers a practical three-part definition. He emphasizes these shared traits as the "beating heart" of shamanism across many settings: - A non-ordinary state (trance, ecstasy, or another altered mode) - Engagement with unseen beings or realities (spirits, gods, ancestors, witches, ghosts) - Services such as healing and divination Singh also explores taboo, restriction, and "otherness." He explains how shamans often cultivate social and psychological distance through initiations, deprivation, and visible markers. This helps communities experience the practitioner as different in kind, which increases credibility when the practitioner claims access to hidden forces. Later Discussion and Takeaways With Manvir Singh Later, Manvir Singh challenges common psychedelic narratives that treat psychedelics as the universal engine of religion or shamanism. He notes that many shamanic traditions do not rely on psychedelics at all, and that rhythmic music, drumming, dance, and social ritual can reliably produce trance states. He also clarifies a key mismatch in many contemporary "ayahuasca tourism" settings: in many traditional contexts, the specialist takes the substance to work on behalf of the patient, rather than turning the participant into the primary visionary practitioner. Practical takeaways for the psychedelic field include: - Use definitions that fit cross-cultural evidence, not marketing language. - Avoid assuming psychedelics are required for mystical experience. - Notice how authority gets built through ritual, training, and otherness, not only through pharmacology.

    Not rated yet
  • PT 645 - Oli Genn-Bash: Functional Mushrooms, Hype Cycles, and Mycelial Thinking

    · 1 hr 14 min

    Oli Genn-Bash (https://thefungiconsultant.com/) (Brighton, UK) joins Joe Moore for a grounded conversation on the boom in functional mushrooms and why the category may be moving too quickly. As the founder of The Fungi Consultant, Oli works with consumers and brands to demystify functional mushrooms, with a focus on education, traceability, and realistic expectations. The conversation begins with a critique of wellness hype cycles. Oli explains how consumer desperation for help with anxiety, sleep, stress, and cognition can create an opening for a rapid wave of products that are not always grounded in careful sourcing or clear science. Using lion's mane as a case study, he contrasts popular cognitive claims with traditional use, arguing that the most useful path forward is to slow down, get more literate about mechanisms, and build a market that can sustain trust over time. Systems and Culture Oli describes how individual health is inseparable from community realities, including food access, class dynamics, and what wellness advice can sound like when it lands from a place of privilege. They discuss mycelial thinking as a practical framework for collaboration and resource-sharing, and why mushrooms tend to attract unusually generous "teach everyone" communities. They also explore the role of mushrooms in meaning-making and consciousness. Oli shares personal reflections on mushrooms as allies, the felt sense of "agency" in psychedelic experiences, and how those experiences can encourage behavioral change without forcing it. The conversation touches on alcohol culture in the UK and the possibility of non-alcoholic alternatives, including how functional mushrooms, microdosing, and other botanicals can support social confidence and energy for some people. Finally, they look ahead at fungal innovation beyond supplements: materials, soil health, regenerative approaches, bioremediation, and what the broader psychedelic movement might learn from fungi's patience, symbiosis, and balance. Key themes and takeaways 1) Why functional mushrooms feel "too fast" right now Oli argues that functional mushrooms have accelerated into a high-pressure wellness marketplace, with brands rushing products to market and consumers struggling to determine what is legitimate, traceable, and effective. He draws parallels to the UK CBD market, describing how oversaturation and inconsistent quality can erode trust and collapse prices. 2) Lion's mane, tradition, and mechanism Lion's mane is a useful example of how modern marketing can outrun nuance. Oli notes the gap between popular cognitive claims and traditional use, and points toward the gut-brain axis as one plausible bridge that requires more careful explanation and patience. 3) "Functional mushrooms" as a frame Oli prefers the term functional mushrooms over medicinal mushrooms, emphasizing systems-level support rather than a pharmaceutical model. He describes a view of health that starts on the cellular level and asks what supports function, resilience, and prevention. 4) Health is individual and collective Oli speaks candidly about barriers to wellness in the UK, including food poverty, access to education about cooking, and how class dynamics shape what health messaging sounds like. The broader point is structural: it is difficult to talk about supplements without considering the baseline conditions of daily life. 5) Mycelial thinking, futures work, and collaboration The conversation highlights "mycelial thinking" as more than a metaphor. Oli describes collaborations in futures-oriented communities and how fungal logic can inform collaboration, non-zero-sum outcomes, and resource sharing. 6) Mushroom culture and the instinct to share Joe notes how strikingly generous mushroom communities can be, especially around cultivation and identification. Oli agrees and adds a provocative angle: the possibility of "agency" in fungi and a sense that mushrooms invite humans into relationship,…

    Not rated yet